Advanced search
Publication Cover
Cutaneous and Ocular Toxicology Volume 30, 2011 - Issue 4
Submit an article Journal homepage
91
Views
3
CrossRef citations to date
0
Altmetric
Case Reports

Subconjunctival bevacizumab for corneal neovascularization secondary to topical anesthetic abuse

Constantine D. GeorgakopoulosUniversity of Patras, Medical School, Department of Ophthalmology, Patras, GreeceCorrespondence[email protected]
,
Panagiotis VasilakisUniversity of Patras, Medical School, Department of Ophthalmology, Patras, Greece
,
Olga E. MakriUniversity of Patras, Medical School, Department of Ophthalmology, Patras, Greece
,
Eleni BeredimaUniversity of Patras, Medical School, Department of Ophthalmology, Patras, Greece
&
Nikolaos PharmakakisUniversity of Patras, Medical School, Department of Ophthalmology, Patras, Greece
Pages 320-322 | Received 16 Feb 2011, Accepted 16 Mar 2011, Published online: 08 Nov 2011

References

  • Chen HT, Chen KH, Hsu WM. Toxic keratopathy associated with abuse of low-dose anesthetic: A case report. Cornea 2004;23:527–529.
  • Rosenwasser GO. Complications of topical ocular anesthetics. Int Ophthalmol Clin 1989;29:153–158.
  • Klebe S, Coster DJ, Williams KA. Rejection and acceptance of corneal allografts. Curr Opin Organ Transplant 2009;14:4–9.
  • Koenig Y, Bock F, Horn F, Kruse F, Straub K, Cursiefen C. Short- and long-term safety profile and efficacy of topical bevacizumab (Avastin) eye drops against corneal neovascularization. Graefes Arch Clin Exp Ophthalmol 2009;247:1375–1382.
  • Varga JH, Rubinfeld RS, Wolf TC, Stutzman RD, Peele KA, Clifford WS et al. Topical anesthetic abuse ring keratitis: Report of four cases. Cornea 1997;16:424–429.
  • Zagelbaum BM, Tostanoski JR, Hochman MA, Hersh PS. Topical lidocaine and proparacaine abuse. Am J Emerg Med 1994;12:96–97.
  • Rosenwasser GO, Holland S, Pflugfelder SC, Lugo M, Heidemann DG, Culbertson WW et al. Topical anesthetic abuse. Ophthalmology 1990;97:967–972.
  • Philipp W, Speicher L, Humpel C. Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas. Invest Ophthalmol Vis Sci 2000;41:2514–2522.
  • DeStafeno JJ, Kim T. Topical bevacizumab therapy for corneal neovascularization. Arch Ophthalmol 2007;125:834–836.
  • Carrasco MA. Subconjunctival bevacizumab for corneal neovascularization in herpetic stromal keratitis. Cornea 2008;27:743–745.
  • Cursiefen C, Hofmann-Rummelt C, Küchle M, Schlötzer-Schrehardt U. Pericyte recruitment in human corneal angiogenesis: An ultrastructural study with clinicopathological correlation. Br J Ophthalmol 2003;87:101–106.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.